Wilmington/Detroit/Oklahoma City — Johnson & Johnson (J&J) took the unusual step of settling three women’s claims that its talc-based products caused their asbestos-linked cancers rather than let juries decide the cases, potentially opening a new front in the growing litigation against the world’s largest maker of healthcare products. Jurors in state court in Oklahoma City on Wednesday spent about three hours weighing up whether J&J’s baby powder was a factor in a 77-year-old woman’s development of peritoneal mesothelioma, when a judge announced the two sides had come to a deal. Details of the accord weren’t made public. On the same day, J&J also reached a confidential settlement that cut short a trial in Los Angeles over a 36-year-old’s claims that products she had used since childhood led to her mesothelioma, an asbestos-linked cancer, and resolved a similar New York case slated for trial in April. Unlike some pharma companies, J&J isn’t known for quickly settling cases, so resolv...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now